Janssen Pharmaceutica (hypoxia-inducible factor) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Janssen Pharmaceutica (hypoxia-inducible factor) General Information
Description
A portfolio of preclinical compounds. The portfolio consists of AKB-5169 and other pharmaceutical compounds which are used in development as an oral treatment for inflammatory bowel disease (IBD).
Contact Information
Corporate Office
- Beerse
- Belgium
Corporate Office
- Beerse
- Belgium
Janssen Pharmaceutica (hypoxia-inducible factor) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Janssen Pharmaceutica (hypoxia-inducible factor) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Janssen Pharmaceutica (hypoxia-inducible factor) FAQs
-
Where is Janssen Pharmaceutica (hypoxia-inducible factor) headquartered?
Janssen Pharmaceutica (hypoxia-inducible factor) is headquartered in Beerse, Belgium.
-
What industry is Janssen Pharmaceutica (hypoxia-inducible factor) in?
Janssen Pharmaceutica (hypoxia-inducible factor)’s primary industry is Buildings and Property.
-
Is Janssen Pharmaceutica (hypoxia-inducible factor) a private or public company?
Janssen Pharmaceutica (hypoxia-inducible factor) is a Private company.
-
What is the current valuation of Janssen Pharmaceutica (hypoxia-inducible factor)?
The current valuation of Janssen Pharmaceutica (hypoxia-inducible factor) is .
-
What is Janssen Pharmaceutica (hypoxia-inducible factor)’s current revenue?
The current revenue for Janssen Pharmaceutica (hypoxia-inducible factor) is .
-
Who are Janssen Pharmaceutica (hypoxia-inducible factor)’s investors?
Johnson&Johnson Innovative Medicine has invested in Janssen Pharmaceutica (hypoxia-inducible factor).
-
When was Janssen Pharmaceutica (hypoxia-inducible factor) acquired?
Janssen Pharmaceutica (hypoxia-inducible factor) was acquired on 13-Feb-2017.
-
Who acquired Janssen Pharmaceutica (hypoxia-inducible factor)?
Janssen Pharmaceutica (hypoxia-inducible factor) was acquired by Akebia Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process